Suspension of Italian medtech price cuts upheld

05/14/2013 | Clinica

An Italian court ruling has upheld the suspension of a government mandate to cut prices for medical devices, invalidating the program that was scheduled to go into effect in January. The court found that the price cuts were based on a faulty use of the national medical device classification system and used inaccurate price sampling. Italian health care authorities must now come up with a different formula for implementing cost controls that recognizes the varied and specialized characteristics of the medtech sector.

View Full Article in:

Clinica

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA